Abstract:Factor-based induced reprogramming approaches have tremendous potential for human regenerative medicine, but the efficiencies of these approaches are still low. In this study, we analyzed the global transcriptional profiles of mouse induced pluripotent stem cells (miPSCs) and mouse embryonic stem cells (mESCs) from seven different labs and present here the first successful clustering according to cell type, not by lab of origin. We identified 2131 different expression genes (DEs) as candidate pluripotency-associated genes by comparing mESCs/miPSCs with somatic cells and 720 DEs between miPSCs and mESCs. Interestingly, there was a significant overlap between the two DE sets. Therefore, we defined the overlap DEs as “consensus DEs” including 313 miPSC-specific genes expressed at a higher level in miPSCs versus mESCs and 184 mESC-specific genes in total and reasoned that these may contribute to the differences in pluripotency between mESCs and miPSCs. A classification of “consensus DEs” according to their different expression levels between somatic cells and mESCs/miPSCs shows that 86% of the miPSC-specific genes are more highly expressed in somatic cells, while 73% of mESC-specific genes are highly expressed in mESCs/miPSCs, indicating that the miPSCs have not efficiently silenced the expression pattern of the somatic cells from which they are derived and failed to completely induce the genes with high expression levels in mESCs. We further revealed a strong correlation between oocyte-enriched factors and insufficiently induced mESC-specific genes and identified 11 hub genes via network analysis. In light of these findings, we postulated that these key hub genes might not only drive somatic cell nuclear transfer (SCNT) reprogramming but also augment the efficiency and quality of miPSC reprogramming.

Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells

Lysosomal Catabolic Activity Promotes the Exit of Murine Totipotent 2-Cell State by Silencing Early-Embryonic Retrotransposons

A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit

Zfp281 Inhibits the Pluripotent-to-Totipotent State Transition in Mouse Embryonic Stem Cells

A transcriptional roadmap for 2C-like-to-pluripotent state transition.

Epigenetic reprogramming in the transition from pluripotency to totipotency

Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression

Remodeling of H3K9me3 During the Pluripotent to Totipotent-Like State Transition

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

The pluripotent-to-totipotent state transition in mESCs activates the intrinsic apoptotic pathway through DUX-induced DNA replication stress

Transition from totipotency to pluripotency in mice: insights into molecular mechanisms

Coordinated repression of totipotency-associated gene loci by histone methyltransferase EHMT2 through binding to LINE-1 regulatory elements

Molecular Mechanisms of Pluripotency and Reprogramming

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Molecular mechanisms underlying totipotency

Systematically Dissecting the Global Mechanism of miRNA Functions in Pluripotent Stem Cells

Histone methyltransferases MLL2 and SETD1A/B play distinct roles in H3K4me3 deposition during the transition from totipotency to pluripotency

Resolution of Reprogramming Transition States by Single Cell RNA-Sequencing

Relaxed 3D genome conformation facilitates the pluripotent to totipotent-like state transition in embryonic stem cells

Epigenetic regulation of reprogramming factors towards pluripotency in mouse preimplantation development

Relaxed 3D Genome Conformation Facilitates the Pluripotent to Totipotent State Transition in Embryonic Stem Cells